Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity

BACKGROUND: Current immunotherapies including checkpoint blockade therapy have limited success rates in certain types of cancers. Identification of alternative checkpoint molecules for the development of effective strategies for tumor immunotherapy is urgently needed. Immunoglobulin-like transcript...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Aiqin, Liu, Xia, Lin, Wenli, Wang, Jingnan, Wang, Shuyun, Si, Fusheng, Huang, Lan, Zhao, Yangjing, Sun, Yuping, Peng, Guangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929805/
https://www.ncbi.nlm.nih.gov/pubmed/33653799
http://dx.doi.org/10.1136/jitc-2020-001536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929805/
https://www.ncbi.nlm.nih.gov/pubmed/33653799
http://dx.doi.org/10.1136/jitc-2020-001536

Ejemplares similares